Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole CR for Parkinson's Disease
NCT00650104Phase 3Completed
- Sponsor
- GSK
- Start
- May 2002
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropinirole in Parkinson's disease (PD), sponsored by GSK. Started May 2002; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00650104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650104.